Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

OpenNIH

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

$5,000,000
Award ceiling
Jul 1, 2028
Closes
View opportunity →
OpenNIH

Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)

$400,000
Award ceiling
Jul 1, 2028
Closes
View opportunity →
OpenNIH

Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)

Jul 7, 2028
Closes
View opportunity →
OpenNIH

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Jul 20, 2028
Closes
View opportunity →
OpenNIH

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)

$2,000,000
Total funding
Aug 21, 2028
Closes
View opportunity →
OpenNIH

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

$3,000,000
Award ceiling
Aug 21, 2028
Closes
View opportunity →
OpenNIH

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

Aug 25, 2028
Closes
View opportunity →
OpenNIH

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)

$100,000
Award ceiling
Sep 7, 2028
Closes
View opportunity →
OpenNIH

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)

$125,000
Award ceiling
Sep 7, 2028
Closes
View opportunity →
OpenNIH

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

Sep 7, 2028
Closes
View opportunity →
OpenNIH

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Sep 7, 2028
Closes
View opportunity →
OpenNIH

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Sep 25, 2028
Closes
View opportunity →